{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T07:23:30Z","timestamp":1785223410507,"version":"3.55.0"},"reference-count":16,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2003,7,31]],"date-time":"2003-07-31T00:00:00Z","timestamp":1059609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2003,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>The current study was performed to analyze the effects of radiotherapy and chemotherapy on visual improvement in patients with choroid metastases (CM), and to determine the clinical factors potentially related to the risk of death.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>One hundred twenty\u2010three consecutive patients were diagnosed with CM at the Institut Gustave\u2010Roussy between 1966 and 1992. Treatment failure was defined as the absence of tumor regression or choroid tumor progression documented at the time of last ophthalmologic examination. The Cox proportional hazards model was used to estimate the risk of treatment failure associated with analyzed covariates.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Approximately 81% of the patients were women. The most frequent primary tumors were breast carcinoma (71%) and lung carcinoma (9%). Bilateral CM were found in 25% of patients. Sequential vinca alkaloid\u2010based chemoradiotherapy was reported to be significantly associated with a decreased rate of treatment failure compared with radiotherapy alone (relative risk [RR] = 0.3; 95% confidence interval [95% CI], 0.03\u20132.2). However, when considered separately, each type of treatment also decreased the risk of treatment failure (RR = 0.5 [95% CI, 0.3\u20130.8] for radiotherapy and RR = 0.4 [95% CI, 0.3\u20130.7] for chemotherapy). The total dose of radiotherapy (&lt; 30 grays [Gy] vs. \u2265 30 Gy) was not found to modify treatment results. The 2\u2010year overall survival rate was 25% (95% CI, 17\u201334%). The risk of death was found to be correlated with the presence of metastases in the liver (<jats:italic>P<\/jats:italic> = 0.02) or lung pleura (<jats:italic>P<\/jats:italic> = 0.04) at the time of the diagnosis of CM.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>Sequential combination radiotherapy and vinca alkaloid\u2010based chemotherapy appear to be the most beneficial treatment modality. However, because treatments were not prescribed randomly, the results of the current study should be interpreted with caution. Cancer 2003;98:1232\u20138. \u00a9 2003 American Cancer Society.<\/jats:p><jats:p>DOI 10.1002\/cncr.11622<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.11622","type":"journal-article","created":{"date-parts":[[2003,9,10]],"date-time":"2003-09-10T09:35:52Z","timestamp":1063186552000},"page":"1232-1238","source":"Crossref","is-referenced-by-count":27,"title":["Choroid metastases: Clinical features and treatments in 123 patients"],"prefix":"10.1002","volume":"98","author":[{"given":"Isabelle","family":"d'Abbadie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Arriagada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Spielmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique G.","family":"L\u00ea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,7,31]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1971.00990050675005"},{"key":"e_1_2_6_3_2","first-page":"37","article-title":"Diagnosis of choroid metastasis","volume":"248","author":"Bourgoignie K","year":"1993","journal-title":"Bull Soc Belge Ophthalmol."},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820201)49:3<578::AID-CNCR2820490330>3.0.CO;2-A"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197609)38:3<1326::AID-CNCR2820380336>3.0.CO;2-#"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1987.01060090073031"},{"issue":"1","key":"e_1_2_6_7_2","first-page":"1","article-title":"Choroid metastasis arising from carcinoma of the breast. Review and analysis of five cases","volume":"17","author":"Halpern J","year":"1986","journal-title":"J Med."},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910801)68:3<623::AID-CNCR2820680330>3.0.CO;2-L"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(97)30148-1"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2517-6161.1972.tb00899.x"},{"issue":"3","key":"e_1_2_6_11_2","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1997.15.3.1244","article-title":"Functional vision is improved in the majority of patients treated with external\u2010beam radiotherapy for choroid metastases: a multivariate analysis of 188 patients","volume":"15","author":"Rudoler SB","year":"1997","journal-title":"J Clin Oncol."},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(97)00050-3"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(77)90085-2"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(99)00135-8"},{"key":"e_1_2_6_15_2","first-page":"889","volume-title":"Diseases of the breast","author":"McCormick BA","year":"2000"},{"key":"e_1_2_6_16_2","first-page":"871","volume-title":"Principles and practice of radiation oncology","author":"Freire JE","year":"1997"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.71.5.348"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.11622","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.11622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:36:13Z","timestamp":1760258173000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.11622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7,31]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,9,15]]}},"alternative-id":["10.1002\/cncr.11622"],"URL":"https:\/\/doi.org\/10.1002\/cncr.11622","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7,31]]}}}